SCORED trial:A Secondary Analysis of the SCORED Trial

A Secondary Analysis of the SCORED Trial

A Secondary Analysis of the SCORED Trial

由VSSridhar著作·2024·被引用4次—Methods:SCOREDwasamulticenter,randomizedtrialevaluatingcardiorenaloutcomeswithsotagliflozinversusplaceboin10,584patientswith ...。其他文章還包含有:「SotagliflozininPatientswithDiabetesandChronicKidney...」、「EffectofSotagliflozinonCardiovascularandRenalEvents...」、「SCOREDTrial」、「NCT03315143」、「SotagliflozinandKidneyOutcomes」、「DidtheSCOREDTrialGetExtra...

查看更多 離開網站

Sotagliflozininpefa
Provide From Google
Sotagliflozin in Patients with Diabetes and Chronic Kidney ...
Sotagliflozin in Patients with Diabetes and Chronic Kidney ...

https://www.nejm.org

We conducted a multicenter, double-blind trial in which patients with type 2 diabetes mellitus (glycated hemoglobin level, ≥7%), chronic kidney ...

Provide From Google
Effect of Sotagliflozin on Cardiovascular and Renal Events ...
Effect of Sotagliflozin on Cardiovascular and Renal Events ...

https://www.acc.org

The SCORED trial showed that sotagliflozin has salutary effects on CV outcomes among patients with T2DM and CKD. Description: The goal of ...

Provide From Google
SCORED Trial
SCORED Trial

https://www.inpefahcp.com

Learn about the SCORED trial in patients with type 2 diabetes mellitus, chronic kidney disease, and cardiovascular risk factors, including a history of ...

Provide From Google
NCT03315143
NCT03315143

https://clinicaltrials.gov

沒有這個頁面的資訊。

Provide From Google
Sotagliflozin and Kidney Outcomes
Sotagliflozin and Kidney Outcomes

https://journals.lww.com

SCORED was a multicenter, randomized trial evaluating cardiorenal outcomes with sotagliflozin versus placebo in 10,584 patients with type 2 diabetes and CKD.

Provide From Google
Did the SCORED Trial Get Extra Points for Kidney ...
Did the SCORED Trial Get Extra Points for Kidney ...

https://journals.lww.com

The two most extensive trials evaluating cardiovascular outcomes in patients receiving sotagliflozin include the SOLOIST-WHF and SCORED trials.

Provide From Google
Sotagliflozin Slows CKD Progression in Patients With T2DM
Sotagliflozin Slows CKD Progression in Patients With T2DM

https://www.uspharmacist.com

The trial revealed that use of the dual sodium-glucose cotransporter (SGLT) 1 and 2 inhibitor sotagliflozin enhances kidney and cardiorenal outcomes in ...